Daniel Macuga - USANA Health Chief Communications and Marketing Officer

USNA Stock  USD 48.50  0.23  0.48%   

Executive

Mr. Daniel A. Macuga Jr., is Chief Communications and Marketing Officer of the Company. Mr. Macuga joined USANA in 2007 as Vice President of Network Development and Public Relations. In July 2008, he was appointed as Vice President of Marketing, Public Relations and Social Media and served in that role until December 2011, when he was appointed Chief Communications Officer. He served in that role until February 2014 when he was appointed Chief Communications Officer and Executive Vice President of Field Development for the Americas. He served in that role until November 2016 when he was appointed Chief Communications Officer. He served in that role until November 2017 when he was named Chief Communications and Marketing Officer. Prior to joining USANA, Mr. Macuga was employed at the Chrysler Corporationrationration, where he spent 15 years working closely with independent dealership entrepreneurs to help them build their businesses, increase awareness for their products, and keep them focused on effective customer relationship management since 2017.
Age 54
Tenure 7 years
Address 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120
Phone801 954 7100
Webhttps://www.usana.com
Macuga received a B.A. in communications from the University of California, San Diego.

USANA Health Management Efficiency

The company has return on total asset (ROA) of 0.0946 % which means that it generated a profit of $0.0946 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1369 %, meaning that it created $0.1369 on every $100 dollars invested by stockholders. USANA Health's management efficiency ratios could be used to measure how well USANA Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Assets is expected to grow to 0.25, whereas Return On Capital Employed is forecasted to decline to 0.26. At present, USANA Health's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 37.4 M, whereas Non Current Assets Total are forecasted to decline to about 110.9 M.
The company currently holds 13.21 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. USANA Health Sciences has a current ratio of 2.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist USANA Health until it has trouble settling it off, either with new capital or with free cash flow. So, USANA Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like USANA Health Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for USANA to invest in growth at high rates of return. When we think about USANA Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Joyce McCarthyCentral Garden Pet
54
Ken ElsburyCentral Garden Pet
N/A
Neil FletcherNomad Foods
N/A
Friederike EdelmannCentral Garden Pet
N/A
Steve ChalloumaNomad Foods
N/A
Matt TalleBorealis Foods
N/A
Sukshma RajagopalanLamb Weston Holdings
N/A
CFA IVKellanova
N/A
George YuhasCentral Garden Pet
65
Pouneh RahimiBorealis Foods
N/A
Charisse HughesKellanova
53
Antje SchubertNomad Foods
N/A
John MinKellanova
44
Victor CadeKellanova
48
Michael FortinNatural Alternatives Internatio
47
William PenningtonCentral Garden Pet
N/A
Shana BowmanNuzee Inc
47
Steve WegrzynBorealis Foods
N/A
Lesley SalmonKellanova
N/A
Chris WalterCentral Garden Pet
N/A
Kris BahnerKellanova
54
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people. USANA Health Sciences (USNA) is traded on New York Stock Exchange in USA. It is located in 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120 and employs 1,800 people. USANA Health is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

USANA Health Sciences Leadership Team

Elected by the shareholders, the USANA Health's board of directors comprises two types of representatives: USANA Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of USANA. The board's role is to monitor USANA Health's management team and ensure that shareholders' interests are well served. USANA Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, USANA Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Timothy Wood, Independent Director
David Wentz, Co-CEO
G Iiekking, CFO
Andrew Masuda, Director Relations
Scott Nixon, Additional Independent Director
Patrique Richards, Executive Development
Donald Williams, Independent Director
Paul Jones, CFO, Principal Accounting Officer and Chief Leadership Devel. Officer
Peggie Pelosi, Independent Director
Frederic Winssinger, Independent Director
Joshua Foukas, General Officer
Jerry McClain, Independent Director
Douglas Hekking, Chief Officer
James Bramble, Chief Legal Officer and Corporate Secretary
John Cuomo, Executive Technology
Douglas Braun, Chief Marketing Officer
Walter Noot, Chief Operating Officer
Brian Dixon, Executive Education
Deborah Woo, President of Asia and Greater China
Richard Williams, Independent Director
P Foukas, Chief Legal Officer, General Counsel and Corporate Secretary
Ronald Poelman, Board Secretary, Independent Director
Donald Wiiliam, Independent Director
Josh Foukas, Executive Vice President - Legal
Feng Peng, Independent Director
Kevin Guest, Chairman of the Board, Chief Executive Officer
Xia Ding, Independent Director
Daniel Macuga, Chief Communications and Marketing Officer
Robert Anciaux, Independent Director
David Mulham, Chief Field Development Officer
Gilbert Fuller, Lead Independent Director
Myron Wentz, Founder and Chairman
John Fleming, Independent Director
Jim Brown, Chief Production Officer
Brent Neidig, Chief Officer and Managing Director of China
G Hekking, Chief Financial Officer
Robert Sinnott, Chief Scientific Officer
Robert Auciaux, Independent Director
Dr MNS, Chief Officer

USANA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is USANA Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for USANA Stock analysis

When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is USANA Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.32
Earnings Share
3.3
Revenue Per Share
47.845
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0946
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.